Skip to main content
Tech.euFundingExplorerBeta

CryoTherapeutics

CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary

CryoTherapeutics has raised €29M across 3 funding rounds from 12 investors, most recently a Series B round in Apr 2024. Based in Awans, Belgium; founded 2009; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€29M
€29,300,000
Funding rounds
3
Investors
12
distinct backers
Active since
2019-07
latest 2024-04

Funding by year

EUR raised per year
CryoTherapeutics — funding by year — interactive chart.
Data table
CryoTherapeutics — funding by year
2019€7.0M
2022€12M
2024€10M

Signals

High confidence
Raise-next likelihood23
base rate 48% for Series B
  • ▼ Past typical raise window
  • ▼ Down/flat last round
  • ▼ Low backer re-investment
Exit likelihood8
base rate 11% (2+ rounds)
  • ▼ Old (17y) — past typical exit age
  • ▼ No recent equity round (debt-only or quiet)

Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

3 rounds

Similar companies

same sector or country

Global coverage: FundingData